Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Wall Street likes the company's promising pipeline ... this weight-loss drug stock could more than 3x over the next 12 ...
In my book, it's a company that's built a long track ... Following in the steps of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback